Controversies in antenatal corticosteroids

Anthony L. Shanks, Jennifer L. Grasch, Sara Quinney, David Haas

Research output: Contribution to journalArticle

Abstract

Antenatal corticosteroids (ACS) successfully reduce the rates of neonatal mortality and morbidity after preterm birth. However, this translational success story is not without controversies. This chapter explores some contemporary controversies with ACS, including the choice of corticosteroid, use in threatened preterm birth less than 24 weeks' gestation, use in late preterm birth, use at term before cesarean delivery, and issues surrounding repeated and rescue dosing of antenatal corticosteroids. The use of ACS in special populations is also discussed. Finally, areas of future research in ACS are presented, focusing on the ability to individualize therapy.

Original languageEnglish (US)
JournalSeminars in Fetal and Neonatal Medicine
DOIs
StatePublished - Jan 1 2019

Fingerprint

Adrenal Cortex Hormones
Premature Birth
Infant Mortality
Morbidity
Pregnancy
Population
Therapeutics

Keywords

  • Antenatal corticosteroids
  • Betamethasone
  • Controversy
  • Dexamethasone
  • Preterm birth

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Controversies in antenatal corticosteroids. / Shanks, Anthony L.; Grasch, Jennifer L.; Quinney, Sara; Haas, David.

In: Seminars in Fetal and Neonatal Medicine, 01.01.2019.

Research output: Contribution to journalArticle

@article{b0b5d7d102b74259975f48d52719bb55,
title = "Controversies in antenatal corticosteroids",
abstract = "Antenatal corticosteroids (ACS) successfully reduce the rates of neonatal mortality and morbidity after preterm birth. However, this translational success story is not without controversies. This chapter explores some contemporary controversies with ACS, including the choice of corticosteroid, use in threatened preterm birth less than 24 weeks' gestation, use in late preterm birth, use at term before cesarean delivery, and issues surrounding repeated and rescue dosing of antenatal corticosteroids. The use of ACS in special populations is also discussed. Finally, areas of future research in ACS are presented, focusing on the ability to individualize therapy.",
keywords = "Antenatal corticosteroids, Betamethasone, Controversy, Dexamethasone, Preterm birth",
author = "Shanks, {Anthony L.} and Grasch, {Jennifer L.} and Sara Quinney and David Haas",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.siny.2019.05.002",
language = "English (US)",
journal = "Current Alzheimer Research",
issn = "1546-9530",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Controversies in antenatal corticosteroids

AU - Shanks, Anthony L.

AU - Grasch, Jennifer L.

AU - Quinney, Sara

AU - Haas, David

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Antenatal corticosteroids (ACS) successfully reduce the rates of neonatal mortality and morbidity after preterm birth. However, this translational success story is not without controversies. This chapter explores some contemporary controversies with ACS, including the choice of corticosteroid, use in threatened preterm birth less than 24 weeks' gestation, use in late preterm birth, use at term before cesarean delivery, and issues surrounding repeated and rescue dosing of antenatal corticosteroids. The use of ACS in special populations is also discussed. Finally, areas of future research in ACS are presented, focusing on the ability to individualize therapy.

AB - Antenatal corticosteroids (ACS) successfully reduce the rates of neonatal mortality and morbidity after preterm birth. However, this translational success story is not without controversies. This chapter explores some contemporary controversies with ACS, including the choice of corticosteroid, use in threatened preterm birth less than 24 weeks' gestation, use in late preterm birth, use at term before cesarean delivery, and issues surrounding repeated and rescue dosing of antenatal corticosteroids. The use of ACS in special populations is also discussed. Finally, areas of future research in ACS are presented, focusing on the ability to individualize therapy.

KW - Antenatal corticosteroids

KW - Betamethasone

KW - Controversy

KW - Dexamethasone

KW - Preterm birth

UR - http://www.scopus.com/inward/record.url?scp=85066287946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066287946&partnerID=8YFLogxK

U2 - 10.1016/j.siny.2019.05.002

DO - 10.1016/j.siny.2019.05.002

M3 - Article

JO - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1546-9530

ER -